MSK Virtual Management of Treatment-Related Adverse Events Symposium

MSK Virtual Management of Treatment-Related Adverse Events Symposium is organized by Memorial Sloan Kettering Cancer Center (MSKCC). This Online CME Course will be held as a fully web-based course on Oct 23 - 24, 2020. 

How many CME/CE credits can be earned by attending MSK Virtual Management of Treatment-Related Adverse Events Symposium?

Accreditation:
AMA Credit Designation Statement:
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.75 Medical Knowledge MOC points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:
On Successful completion of this CME activity, a participant will be able to apply for the evaluation component, allowing the participant to earn up to 6.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points commensurate to the amount of CME credits claimed for the activity. It is the responsibility of a CME activity provider to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

What is the significance of MSK Virtual Management of Treatment-Related Adverse Events Symposium?

Course Overview:
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

2020 Symposium Highlights:
• Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
• With enhanced survival and patients living longer on therapy, adverse events influencing the quality of life and clinical outcome command attention
• Lectures directed on immune-related adverse events will explain the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
• Up-to-date information will be exhibited on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
• Practical strategies to recognize patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers.
• Innovative strategies to monitor and manage symptoms of patients on active anticancer treatment will be considered including patient-reported outcomes and teleoncology visits.

What are the objectives of MSK Virtual Management of Treatment-Related Adverse Events Symposium?

Course Objectives:
• Identify the clinical presentation and influence on the quality of life of treatment-related adverse events
• Conjecture mechanisms to identify and triage patients at high risk for the development of toxicities
• Review procedures and clinical strategies to prevent and treat adverse events in patients with cancer